- Home
- BHC vs LGND Comparison
BHC vs LGND Comparison
Compare BHC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHC
- LGND
- Stock Information
- Founded
- BHC N/A
- LGND 1987
- Country
- BHC Canada
- LGND United States
- Employees
- BHC N/A
- LGND N/A
- Industry
- BHC Biotechnology: Pharmaceutical Preparations
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- BHC Health Care
- LGND Health Care
- Exchange
- BHC Nasdaq
- LGND Nasdaq
- Market Cap
- BHC 2.3B
- LGND 2.0B
- IPO Year
- BHC N/A
- LGND 1992
- Fundamental
- Price
- BHC $6.85
- LGND $112.84
- Analyst Decision
- BHC Hold
- LGND Strong Buy
- Analyst Count
- BHC 5
- LGND 8
- Target Price
- BHC $7.20
- LGND $144.71
- AVG Volume (30 Days)
- BHC 3.0M
- LGND 135.8K
- Earning Date
- BHC 07-31-2025
- LGND 08-05-2025
- Dividend Yield
- BHC N/A
- LGND N/A
- EPS Growth
- BHC N/A
- LGND N/A
- EPS
- BHC N/A
- LGND N/A
- Revenue
- BHC $9,731,000,000.00
- LGND $181,488,000.00
- Revenue This Year
- BHC $3.71
- LGND $18.41
- Revenue Next Year
- BHC $5.03
- LGND $18.87
- P/E Ratio
- BHC N/A
- LGND N/A
- Revenue Growth
- BHC 8.53
- LGND 53.40
- 52 Week Low
- BHC $3.96
- LGND $81.74
- 52 Week High
- BHC $9.85
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- BHC 78.05
- LGND 55.69
- Support Level
- BHC $6.38
- LGND $112.77
- Resistance Level
- BHC $6.81
- LGND $118.58
- Average True Range (ATR)
- BHC 0.31
- LGND 3.27
- MACD
- BHC 0.09
- LGND -0.15
- Stochastic Oscillator
- BHC 91.29
- LGND 39.63
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.